pharmaceuticals
Pakistan’s drug import dependence poses risks to critical medicine supply
Pakistan’s drug import dependence poses risks to critical medicine supply
Pharmaceutical imports are expected to reach $920m by 2029.
Abu Dhabi and Abbott partner to localise pharmaceutical manufacturing
One key area is the development of biosimilars.
KFSHRC, Germfree to launch modular ATMP manufacturing campus
The facility will be located at the hospital’s main campus in Riyadh.
Global biosimilars market to hit $72.3b by 2035
Thanks to the rising number of regulatory approvals.
India’s rising obesity cases open market opportunities for drugmakers
Diagnosed prevalent cases are expected to increase to 14.63 million in 2031.
India’s pharma industry to face ongoing scrutiny over quality issues
A recent FDA announcement presents risks for the country’s sector.
China’s biopharma sector strikes $30b in oncology licensing deals
Antibody-drug conjugates dominated licensing activity in 2024.
Global radiopharmaceuticals market to be valued at $12.2b by 2030
Its growth is attributed to a rise in cancer and cardiovascular diseases.
7MM HIV market to be valued at $32.1b by 2033
Thanks to the increased uptake of long-acting injectable therapies.
APAC’s price controls, tendering processes pose risks to pharma firms
Such practices could impact revenues and market access.
APAC’s HTA adoption to grow amidst infrastructure, talent challenges
Key markets include Indonesia, the Philippines, and Australia.
Oral proteins and peptides market to hit $24b by 2030
Its expansion is attributed to the prevalence of chronic diseases like diabetes.
7MM COPD market to hit $30.2b in 2033
Triple therapy inhalers are expected to account for 11.3% of the total market.
Japan’s 10-year fund to boost pharmaceutical landscape
The country’s ageing population is driving demand for innovative treatments.
Saudi Arabia’s pharmaceutical market to hit $16.7b by 2029
Thanks to rising investments and increased international collaboration.
South Korea, China lead degrader-antibody conjugate development: report
Companies from these countries collectively account for 19 out of 28 assets worldwide.
India’s pharmaceutical market to reach $41.4b by 2029
This expansion is supported by ongoing public sector efforts.
Most Read
1. NHG Health, ST Engineering sign five-year deal to develop smart systems 2. What factors drive the Asia Pacific’s Gaucher disease treatment market? 3. NDCS launches AI dental scanner for fast home and clinic checks 4. Global pulse oximeters market to reach $7.03b by 2032 5. Most older adults in Hong Kong lack life and death education: reportResource Center
Read Here
Advertise
Sign Up
Event News
The medical institution earned recognition for its National Hospital Apps which have brought digital revolution in healthcare.
Commentary
The shift towards cognitive healthcare platforms leveraging AI, IoT, and Blockchain